Prenatal care, pregnancy outcomes, and postpartum birth control plans among pregnant women with opiate addictions

Southern Medical Journal

Volumn 107, Issue 11, 2014, Pages 676-683

  Parlier, Anna Beth ^a,b   Fagan, Blake ^a,b   Ramage, Melinda ^a,b   Galvin, Shelley ^a,b  

^a MAHEC   (United States)

^b Mountain Area Health Education Center   (United States)

Author keywords

Medication maintenance therapy; Neonatal abstinence syndrome; Opioid addiction; Postpartum contraception

Indexed keywords

BUPRENORPHINE; BUPRENORPHINE PLUS NALOXONE; ILLICIT DRUG; METHADONE; OPIATE DERIVATIVE;

ADULT; ARTICLE; BIRTH CONTROL; CAUCASIAN; CONTRACEPTION; FEMALE; HIGH RISK PREGNANCY; HUMAN; INFANT; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MATERNAL CARE; MEDICAL DOCUMENTATION; MULTIPARA; NEWBORN; OPIATE ADDICTION; PAIN; PATIENT COMPLIANCE; PATIENT COUNSELING; PATIENT SCHEDULING; PREDICTION; PREGNANCY OUTCOME; PREGNANT WOMAN; PREMATURE LABOR; PREMATURITY; PRENATAL CARE; PRESCRIPTION; PUERPERIUM; RETROSPECTIVE STUDY; UNPLANNED PREGNANCY; WITHDRAWAL SYNDROME; CONTRACEPTIVE BEHAVIOR; COUNSELING; NEONATAL ABSTINENCE SYNDROME; POSTNATAL CARE; PREGNANCY; PREGNANCY COMPLICATION;

CONTRACEPTION BEHAVIOR; COUNSELING; FEMALE; HUMANS; NEONATAL ABSTINENCE SYNDROME; OPIOID-RELATED DISORDERS; POSTNATAL CARE; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY OUTCOME; PREGNANCY, HIGH-RISK; PREGNANCY, UNPLANNED; PRENATAL CARE;

EID: 84922391340     PISSN: 00384348     EISSN: 15418243     Source Type: Journal    
DOI: 10.14423/SMJ.0000000000000189     Document Type: Article

References (46)

1. Patrick SW, Schumacher RE, Benneyworth BD, et al. Neonatal abstinence syndrome and associated health care expenditures: United States, 2000-2009. JAMA 2012;307:1934-1940.
2. Logan BA, Brown MS, Hayes MJ. Neonatal abstinence syndrome: treatment and pediatric outcomes. Clin Obstet Gynecol 2013;56:186-192.
3. ACOG Committee on Health Care for Underserved Women; American Society of Addiction Medicine. ACOG Committee Opinion No. 524: opioid abuse, dependence, and addiction in pregnancy. Obstet Gynecol 2012;119:1070-1076.
4. Fajemirokun-Odudeyi O, Sinha C, Tutty S, et al. Pregnancyoutcome inwomen who use opiates. Eur J Obstet Gynecol Reprod Biol 2006;126:170-175.
5. Dryden D, Young D, Hepburn M, et al. Maternal methadone use in pregnancy: factors associated with the development of neonatal abstinence syndrome and implications for healthcare resources. BJOG 2009;116:665-671.
6. Pritham UA, Paul JA, Hayes MJ. Opioid dependency in pregnancy and length of stay for neonatal abstinence syndrome. J Obstet Gynecol Neonatal Nurs 2012;41:180-190.
7. Finnegan LP, Hagan T, Kaltenbach KA. Scientific foundation of clinical practice: opiate use in pregnant women. Bull N Y Acad Med 1991;67:223-239.
8. Osborn DA, Jeffery HE, Cole MJ. Opiate treatment for opiate withdrawal in newborn infants. Cochrane Database Syst Rev 2010;10:CD002059.
9. Velez M, Jansson LM. The opioid dependent mother and newborn dyad: non-pharmacologic care. J Addict Med 2008;2:113-120.
10. Seligman NS, Almario CV, Hayes EJ, et al. Relationship between maternal methadone dose at delivery and neonatal abstinence syndrome. J Pediatr 2010;157:428-433.
11. Seligman NS, Salva N, Hayes EJ, et al. Predicting length of treatment for neonatal abstinence syndrome in methadone-exposed neonates. Am J Obstet Gynecol 2008;199:396.e1-396.e7.
12. Ordean A, Kahan M. Comprehensive treatment program for pregnant substance users in a family medicine clinic. Can Fam Physician 2011;57:e430-e435.
13. Kukko H, Halmesmäki E. Prenatal care and counseling of female drugabusers: effects of drug abuse and perinatal outcome. Acta Obstet Bynecol Scand 1999;78:22-26.
14. Phillips D, Thomas K, Cox H. Factors that influence women's disclosures of substance use during pregnancy: a qualitative study of ten midwives and ten pregnant women. J Drug Issues 2007;2:357-376.
15. Clark KA, Dee DL, Bale PL, et al. Treatment compliance among prenatal care patients with substance abuse problems. Am J Drug Alcohol Abuse 2001;27:121-136.
16. Schempf AH, Strobino DM. Drug use and limited prenatal care: an examination of responsible barriers. Am J Obstet Gynecol 2009;200:412e1-412e10.
17. Brady TM, Visscher W, Feder M, et al. Maternal drug use and the timing of prenatal care. J Health Care Poor Underserved 2003;14:588-607.
18. Goldenberg RL, Patterson ET, Freese MP. Maternal demographic, situational and psychosocial factors and their relationship to enrollment in prenatal care: a review of the literature. Women Health 1992;19:133-151.
19. Harvey SM, Faber KS. Obstacles to prenatal care following implementation of a community-based program to reduce financial barriers. Fam Plann Perspect 1993;25:32-36.
20. Heil SH, Jones HE, Arria A, et al. Unintended pregnancy in opioidabusing women. J Subst Abuse Treat 2011;40:199-202.
21. Mosher WD, Jones J, Abma JC. Intended and unintended births in the United States: 1982-2010. http://www.cdc.gov/nchs/data/nhsr/nhsr055.pdf. Published 2012. Accessed January 3, 2014.
22. Black KI, Stephens C, Haber PS, et al. Unplanned pregnancy and contraceptive use in women attending drug treatment services. Aust N Z J Obstet Gynaecol 2012;52:146-150.
23. Cleary BJ, Eogan M, O'Connell MP, et al. Methadone and perinatal outcomes: a prospective cohort study. Addiction 2012;107:1482-1492.
24. Ebner N, Rohrmeister K, Winklbaur B, et al. Management of neonatal abstinence syndrome in neonates born to opioid maintained women. Drug Alcohol Depend 2007;87:131-138.
25. Funai EF, White J, Lee MJ, et al. Compliance with prenatal care visits in substance abusers. J Matern Fetal Neonatal Med 2003;14:329-332.
26. Standards for Obstetric-Gynecologic Services. 6th ed. Washington, DC: American College of Obstetricians and Gynecologists; 1985.
27. Hernandez LE, Sappenfield WM, Goodman D, et al. Is effective contraceptive use conceived prenatally in Florida? The association between prenatal contraceptive counseling and postpartum contraceptive use. Matern Child Health J 2012;16:423-429.
28. Jones J, Mosher WD, Daniels K. Current contraceptive use in the United States, 2006-2010, and changes in patterns of use since 1995. http://www.cdc.gov/nchs/data/nhsr/nhsr060.pdf. Published October 18, 2012. Accessed April 4, 2014.
29. Morrison CL, Reuben SM, Beeching NJ. Female sexual health problems in a drug dependency unit. Int J STD AIDS 1995;6:201-203.
30. Guttmacher Institute. Fact sheet: contraceptive use in the United States. http://www.guttmacher.org/pubs/fb-contr-use.html. Published June 2014. Accessed September 18, 2014.
31. Sinha C, Guthrie KA, Lindow SW. A survey of postnatal contraception in opiate-using women. J Fam Plann Reprod Health Care 2007;33:31-34.
32. American College of Obstetricians and Gynecologists Committee on Gynecologic Practice; Long-Acting Reversible Contraception Working Group. ACOG Committee Opinion no. 450: increasing use of contraceptive implants and intrauterine devices to reduce unintended pregnancy. Obstet Gynecol 2009;114:1434-1438.
33. Dempsey AR, Billingsley CC, Savage AH, et al. Predictors of long-acting reversible contraception use among unmarried young adults. Am J Obstet Gynecol 2012;206:526.e1-e5.
34. Peipert JF, Madden T, Allsworth JE, et al. Preventing unintended pregnancies by providing no-cost contraception. Obstet Gynecol 2012;120:1291-1297.
35. Rama Rao S, Lacuesta M, Costello M, et al. The link between quality of care and contraceptive use. Int Fam Plann Perspect 2003;29:76-83.
36. Berenson AB, Wiemann CM. Contraceptive use among adolescent mothers at 6 months postpartum. Obstet Gynecol 1997;89:999-1005.
37. Centering Healthcare Institute. Centering pregnancy overview. http://www.centeringhealthcare.org/pages/centering-model/pregnancy-overview.php. Published 2014. Accessed June 30, 2014.
38. Hale N, Picklesimer AH, Billings DL, et al. The impact of Centering Pregnancy Group prenatal care on postpartum family planning. Am J Obstet Gynecol 2014;210:50.e1-50.e7.
39. Niccols A, Milligan K, Sword W, et al. Maternal mental health and integrated programs for mothers with substance abuse issues. Psychol Addict Behav 2010;24:466-474.
40. Sweeney PJ, Schwartz RM, Mattis NG, et al. The effect of integrating substance abuse treatment with prenatal care on birth outcome. J Perinatol 2000;20:219-224.
41. Ordean A, Kahan M. Comprehensive treatment program for pregnant substance users in a family medicine clinic. Can Fam Physician 2011;57:e430-e435.
42. Jansson LM, Svikis D, Lee J, et al. Pregnancy and addiction: a comprehensive care model. J Subst Abuse Treat 1996;13:321-329.
43. Tocce KM, Sheeder JL, Teal SB. Rapid repeat pregnancy in adolescents: do immediate postpartum contraceptive implants make a difference? Am J Obstet Gynecol 2012;206:481.e1-481.e7.
44. Health Management Associates. Medicaid reimbursement for immediate post-partum LARC. https://www.acog.org/~/media/Departments/LARC/HMAPostpartumReimbursmentResource.pdf. Published May 2013. Accessed June 30, 2014.
45. Issel LM. Women's perceptions of outcomes of prenatal case management. Birth 2000;27:120-126.
46. Sangalang BB, Barth RP, Painter JS. First-birth outcomes and timing of second births: a statewide case management program for adolescent mothers. Health Soc Work 2006;31:54-63.